Centurion Therapeutics Inc. is pleased to announce that orthopedic industry veteran, Keegan Begley, has joined the Company as Vice President of Sales. In this role, Keegan and his team will accelerate the Company's revenue growth through expansion into new geographies, development of new sales channels, and contributing to the company’s overall business strategy.
Keegan brings over 10 years of medical device sales and leadership experience to Centurion. Prior to joining Centurion, Keegan gained notoriety through rapidly growing Orthofix’s Trinity allograft franchise as a Regional Sales Manager. Prior to Orthofix, Keegan held several sales leadership positions with SI-Bone, Lanx, and NuVasive Inc., where he received multiple recognition awards. He is a graduate of University of Kansas where he earned a bachelor’s degree in Biology.
"Keegan is a fantastic and timely addition to Centurion. He brings a deep understanding and passion for MTF Biologics’ advanced healing tissues and what it takes to deliver growth in this market," said Robert Goodwin, President and CEO of Centurion. "As Centurion looks forward to future success with the MTF Biologics Wound Care portfolio, Keegan’s sales leadership and his strong background in building top performing sales teams will provide immediate positive impact to Centurion’s growth. We are excited to have him as part of the team."
"I couldn't be more excited to join the Centurion Therapeutics team. I've been fortunate to represent MTF tissues during my career, and this is an incredibly unique opportunity to continue doing so with a world-class, non-profit organization dedicated to saving and healing the lives of patients suffering from chronic and acute non-healing wounds. Centurion and MTF Biologics are perfectly positioned to rapidly expand their market share and I'm honored to play a part in the success to come," stated Keegan Begley, VP of Sales, Centurion.
About Centurion Therapeutics: Centurion Therapeutics is an exclusive distribution partner of MTF Biologics® for their Wound Care portfolio for the advanced treatment of chronic wounds. Further information about Centurion Therapeutics can be found at www.centuriontherapeutics.com.